Publikationen in Zusammenarbeit mit Forschern von Mutua de Terrassa (20)

2023

  1. Association of Time of Day with Outcomes among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia

    Stroke, Vol. 54, Núm. 3, pp. 770-780

  2. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  3. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

  4. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia

    European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565

2022

  1. Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020

    Stroke, Vol. 53, Núm. 11, pp. 3289-3294

  2. The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm

    Journal of Stroke and Cerebrovascular Diseases, Vol. 31, Núm. 1

  3. Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke

    Annals of Neurology, Vol. 92, Núm. 6, pp. 931-942

2021

  1. Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia

    Cerebrovascular Diseases, Vol. 50, Núm. 5

  2. Effectiveness of thrombectomy in stroke according to baseline prognostic factors: Inverse probability of treatment weighting analysis of a populationbased registry

    Journal of Stroke, Vol. 23, Núm. 3, pp. 401-410

  3. Impact of COVID-19 infection on the outcome of patients with ischemic stroke

    Stroke, Vol. 52, Núm. 12, pp. 3908-3917

2020

  1. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

  2. Vascular Occlusion Evolution in Endovascular Reperfusion Candidates Transferred from Primary to Comprehensive Stroke Centers

    Cerebrovascular Diseases, Vol. 49, Núm. 5, pp. 550-555

2019

  1. Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

  2. Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis

    Journal of the American Geriatrics Society, Vol. 65, Núm. 9, pp. E117-E122

2016

  1. Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña

    Neurologia, Vol. 31, Núm. 9, pp. 592-598

2014

  1. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study

    Cerebrovascular Diseases, Vol. 38, Núm. 5, pp. 328-336

  2. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy

    Stroke, Vol. 45, Núm. 4, pp. 1046-1052

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218

2009

  1. Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico

    Neurologia, Vol. 24, Núm. 6, pp. 366-372